PLASMA IDOL, SOLUBLE LDLR AND PCSK9 LEVELS AS POTENTIAL BIOMARKERS OF FAMILIAL HYPERCHOLESTEROLEMIA IN CHILDREN

被引：0
|
作者：
Girona, J. [1 ]
Rodriguez-Borjabad, C. [2 ]
Ibarretxe, D. [2 ]
Heras, M. [1 ]
Amigo, N. [3 ]
Feliu, A. [4 ]
Masana, L. [1 ,2 ]
Plana, N. [2 ]
机构：
[1] URV, CIBERDEM, IISPV, Res Unit Lipids & Atherosclerosis, Reus, Spain
[2] URV, St Joan Univ Hosp, CIBERDEM, IISPV,Vasc Med & Metab Unit, Reus, Spain
[3] URV, CIBERDEM, IISPV, Biosfer Teslab, Reus, Spain
[4] Univ Rovira & Virgili, IISPV, Pediat Res Unit, Reus, Spain
来源：
ATHEROSCLEROSIS | 2018年 / 275卷
关键词：
D O I：
10.1016/j.atherosclerosis.2018.06.051
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAG3.3
引用
收藏
页码：E22 / E22
页数：1
相关论文
共 50 条
  • [31] PCSK9 as predictor for recurrent cardiovascular disease in familial hypercholesterolemia
    Reeskamp, Laurens F.
    Tromp, Tycho R.
    Hovingh, G. Kees
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2021, 28 (03) : 270 - 271
  • [32] PCSK9 gene analysis in Portuguese patients with familial hypercholesterolemia
    Alves, A. C.
    Rato, Q.
    Furtado, A.
    Bourbon, M.
    ATHEROSCLEROSIS SUPPLEMENTS, 2007, 8 (01) : 214 - 215
  • [33] PCSK9 inhibition, a potential target to reduce cardiovascular events in patients with familial hypercholesterolemia
    Marques, Patrice
    Domingo, Elena
    Rubio, Arantxa
    Martinez-Hervas, Sergio
    Piqueras, Laura
    Tomas Real, Jose
    Francisco Ascaso, Juan
    Jesus Sanz, Maria
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2019, 125 : 35 - 35
  • [34] A Novel Cause of Familial Hypercholesterolemia: PCSK9 Gene Duplication
    Paquette, Martine
    Baass, Alexis
    CANADIAN JOURNAL OF CARDIOLOGY, 2018, 34 (10) : 1259 - 1260
  • [35] SCREENING OF PCSK9 GENE IN INDIAN FAMILIAL HYPERCHOLESTEROLEMIA PATIENTS
    Reddy, L. L.
    Ponde, C. K.
    Rajani, R. M.
    Pillai, S.
    Dalal, R. J.
    Vanjani, C. V.
    Dalal, J.
    Ashavaid, T. F.
    ATHEROSCLEROSIS, 2019, 287 : E212 - E212
  • [36] Familial hypercholesterolemia: functional characterization of new variants in PCSK9
    Rodriguez-Novoa, S.
    Rodriguez-Jimenez, C.
    Sanchez-Nieves, E.
    Carazo-Alvarez, A.
    Arrieta, F.
    Reinares-Garcia, L.
    Martinez-Hernandez, P.
    Canas, R.
    Mostaza, J.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 1326 - 1326
  • [37] PCSK9 inhibition in children with familial hypercholesterolaemia
    Hegele, Robert A.
    LANCET DIABETES & ENDOCRINOLOGY, 2022, 10 (10): : 686 - 688
  • [38] INSIGHTS INTO THE VIETNAM FAMILIAL HYPERCHOLESTEROLEMIA REGISTRY: CHARACTERIZING MUTATIONS IN LDLR, APOB AND PCSK9 PROTEINS AT A STRUCTURAL AND FUNCTIONAL LEVEL
    Kim, Thanh
    Ngoc Nguyen
    Tung Le
    An Le
    Loi Do
    Huong Truong
    ATHEROSCLEROSIS, 2024, 395
  • [39] LDLR and PCSK9 3´UTR variants and their putative effects on microRNA molecular interactions in familial hypercholesterolemia: a computational approach
    Renata Caroline Costa de Freitas
    Raul Hernandes Bortolin
    Jessica Bassani Borges
    Victor Fernandes de Oliveira
    Carolina Dagli-Hernandez
    Elisangela da Silva Rodrigues Marçal
    Gisele Medeiros Bastos
    Rodrigo Marques Gonçalves
    Andre Arpad Faludi
    Vivian Nogueira Silbiger
    André Ducati Luchessi
    Rosario Dominguez Crespo Hirata
    Mario Hiroyuki Hirata
    Molecular Biology Reports, 2023, 50 : 9165 - 9177
  • [40] Mutational Spectrum of LDLR and PCSK9 Genes Identified in Iranian Patients With Premature Coronary Artery Disease and Familial Hypercholesterolemia
    Moradi, Arman
    Maleki, Majid
    Ghaemmaghami, Zahra
    Khajali, Zahra
    Noohi, Feridoun
    Moghadam, Maryam Hosseini
    Kalyinia, Samira
    Mowla, Seyed Javad
    Seidah, Nabil G.
    Malakootian, Mahshid
    FRONTIERS IN GENETICS, 2021, 12
12345